8-KThe WireRoutine
Reg FD Disclosure
Filed Sep 14, 2020 · 5y ago · Accession 0001104659-20-104553
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- 8-K
- Filing date
- Sep 14, 2020
- Report date
- Sep 14, 2020
- Document
- tm2030591-1_8k.htm
- Size
- 5.8 MB